The vision of our Senior Management Team is that every client will experience complete confidence in the knowledge, abilities and reliability of our staff, and will see clear benefits and results from our involvement in their projects.
Scott McGregor Managing Director & SAS Solution Specialist
Click to
Scott started working as a SAS Programmer 1990 and, before founding
S-cubed ApS in 2007, he worked in various industries, including the pharmaceutical, finance, transport and public sectors. He has exceptional knowledge of SAS and specialises in web-based application development. Scott has in depth knowledge in application development, data conversion, reporting and submission projects, and has worked extensively on projects involving the implementation and utilisation of CDISC standards.
Mark Lipscombe Managing Director
Click to
Prior to founding S-cubed Ltd with Scott and Martin in 2008, Mark had worked in the pharmaceutical industry for 10 years, most recently as a Principal Consultant with PA Consulting Group’s Life Sciences and Healthcare Practice, based in London. During his time as a consultant, Mark has worked with a wide variety of groups including pharmaceutical, biotechnology and investment companies. Prior to entering consultancy, Mark spent 6 years working in the drug development industry as a Clinical Project Manager.
Mark Baillet Managing Director & Consultant Statistician
Click to
Prior to taking the Managing Director position for S-cubed Biometrics Ltd in May 2011, Mark was Vice President, Data Sciences at SRA Global Clinical Development, where he successfully formed, grew and led the global Biometrics department. Mark has 22 years’ experience in conducting, managing and leading statistics, programming and data management functions within small and large pharmaceutical and biotech companies, including positions at Pfizer and British Biotech. Mark is a chartered statistician with expertise in statistical consultancy, biometrics project management, statistical programming, drug development and commercial business strategy.
Stephen Thompson Director of Regulatory Affairs
Click to
Stephen joined S-cubed Ltd in early 2009, bringing over ten years’ regulatory affairs experience, most recently as a Director in the Regulatory Affairs group at Constella Group (formerly Origin Pharmaceutical Services). Stephen has provided regulatory support to a number of pharmaceutical and biotechnology companies and has worked with most European regulatory agencies and the US FDA. He has a proven track-record of successfully supporting products through development to registration and subsequent license maintenance. Stephen holds a PhD in Chemistry.
Niels Both Data Standardisation and Implementation Specialist
Click to
Niels has worked with clinical data handling and reporting since 1997, and has specialised in implementation of standard data models and standard reporting tools. Since 2004 Niels' focus has been on the use of CDISC standards for FDA submissions, data warehousing and standardisation of dataflow processes from protocol to submission. Niels is an active member of the European CDISC Co-ordination Committee - e3c, and as part of this committee is working on several CDISC models, including SDTM, ADaM and CDASH. Niels joined S-cubed ApS in 2008.
Jack Jacobsen Director of QlikView Development
Click to
Working in clinical data-handling and reporting since 1993, Jack specialises in SAS programming, application development and implementation of reporting tools. Jack has considerable experience of working with clinical as well as pharmacovigilance data, with responsibilities for all linked systems for reporting, compliance and data entry. Jack was the project lead for two eClinical projects, heading a complex data handling and reporting project and an output project focusing on utilising the reporting benefits from standards by means of advanced statistical reporting tools, as well as the use of QlikView Business Intelligence. Before joining S-cubed in 2010, Jack was responsible for coordinating QlikView Business Intelligence development and implementation within a large pharmaceutical company, including exploring new business opportunities for the future use of Business Intelligence.